Randomised, placebo-controlled Phase II proof of concept study of efficacy and safety of a novel rifamycin SV in situ gelling rectal solution administered by enema to patients with mild to moderate left-sided ulcerative colitis - CB-01-35/01
100 Clinical Results associated with COSMO TECH Co., Ltd.
0 Patents (Medical) associated with COSMO TECH Co., Ltd.
100 Deals associated with COSMO TECH Co., Ltd.
100 Translational Medicine associated with COSMO TECH Co., Ltd.